The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ), Illumina (NASDAQ: ILMN ) and Vertex Pharmaceuticals (NASDAQ: VRTX ) grew somewhat between the January